Abiopharma

New Form 8-K - Edgewise Therapeutics, Inc. Filed: 2025-06-26 AccNo: 0001104659-25-063028 Size: 485 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits